{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:42:08Z","timestamp":1790264528230,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1093\/hmg\/ddy437","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T12:11:22Z","timestamp":1545135082000},"page":"1463-1473","source":"Crossref","is-referenced-by-count":12,"title":["Vulnerability of frontal brain neurons for the toxicity of expanded ataxin-3"],"prefix":"10.1093","volume":"28","author":[{"given":"Jana","family":"Schmidt","sequence":"first","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja K","family":"Mayer","sequence":"additional","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bakula","sequence":"additional","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Freude","sequence":"additional","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonasz J","family":"Weber","sequence":"additional","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weiss","sequence":"additional","affiliation":[{"name":"Evotec AG, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schmidt","sequence":"additional","affiliation":[{"name":"SCA3 research group, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany"},{"name":"Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany"},{"name":"NGS Competence Center, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"2019041604484145800_ref1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12311-008-0013-4","article-title":"SCA3: neurological features, pathogenesis and animal models","volume":"7","author":"Riess","year":"2008","journal-title":"Cerebellum"},{"key":"2019041604484145800_ref2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrg1691","article-title":"Diseases of unstable repeat expansion: mechanisms and common principles","volume":"6","author":"Gatchel","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"2019041604484145800_ref3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","article-title":"Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7","volume":"104","author":"Rub","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"2019041604484145800_ref4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pneurobio.2011.06.007","article-title":"Polyglutamine diseases: the special case of ataxin-3 and Machado\u2013Joseph disease","volume":"95","author":"Matos","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"2019041604484145800_ref5","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-012-1000-x","article-title":"Brain pathology of spinocerebellar ataxias","volume":"124","author":"Seidel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"2019041604484145800_ref6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/ene.12559","article-title":"Cerebral cortex involvement in Machado\u2013Joseph disease","volume":"22","author":"","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"2019041604484145800_ref7","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1093\/hmg\/ddp381","article-title":"Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3","volume":"18","author":"Boy","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"2019041604484145800_ref8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuroimage.2006.05.055","article-title":"Expression mapping of tetracycline-responsive prion protein promoter: digital atlasing for generating cell-specific disease models","volume":"33","author":"Boy","year":"2006","journal-title":"Neuroimage"},{"key":"2019041604484145800_ref9","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1523\/JNEUROSCI.3040-07.2008","article-title":"Neurodegeneration and motor dysfunction in a conditional model of Parkinson\u2019s disease","volume":"28","author":"Nuber","year":"2008","journal-title":"J. Neurosci."},{"key":"2019041604484145800_ref10","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neuroimage.2010.11.032","article-title":"Atlas of transgenic Tet-Off Ca2+\/calmodulin-dependent protein kinase II and prion protein promoter activity in the mouse brain","volume":"54","author":"Odeh","year":"2011","journal-title":"Neuroimage"},{"key":"2019041604484145800_ref11","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.274.5293.1678","article-title":"Control of memory formation through regulated expression of a CaMKII transgene","volume":"274","author":"Mayford","year":"1996","journal-title":"Science"},{"key":"2019041604484145800_ref12","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/hmg\/ddm185","article-title":"Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis","volume":"16","author":"Alvarez-Saavedra","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2019041604484145800_ref13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"key":"2019041604484145800_ref14","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1371\/journal.pmed.0020355","article-title":"Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease","volume":"2","author":"Jankowsky","year":"2005","journal-title":"PLoS Med."},{"key":"2019041604484145800_ref15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein","volume":"64","author":"Lin","year":"2009","journal-title":"Neuron"},{"key":"2019041604484145800_ref16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1523\/JNEUROSCI.2824-07.2008","article-title":"The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy","volume":"28","author":"Mocanu","year":"2008","journal-title":"J. Neurosci."},{"key":"2019041604484145800_ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.070693","article-title":"Neurodegeneration and neuroinflammation in cdk5\/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration","volume":"172","author":"Muyllaert","year":"2008","journal-title":"Am. J. Pathol."},{"key":"2019041604484145800_ref18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.mp.4002079","article-title":"Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia","volume":"13","author":"Pletnikov","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"2019041604484145800_ref19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"2019041604484145800_ref20","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1523\/JNEUROSCI.0185-08.2008","article-title":"The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"2019041604484145800_ref21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"2019041604484145800_ref22","doi-asserted-by":"crossref","first-page":"18206","DOI":"10.1073\/pnas.0407976101","article-title":"Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo","volume":"101","author":"Dittgen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019041604484145800_ref23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"2019041604484145800_ref24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","article-title":"An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients","volume":"8","author":"Schmidt","year":"1998","journal-title":"Brain Pathol."},{"key":"2019041604484145800_ref25","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci."},{"key":"2019041604484145800_ref26","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2019041604484145800_ref27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","article-title":"Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"2019041604484145800_ref28","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1523\/JNEUROSCI.2734-04.2004","article-title":"A mutant ataxin-3 putative-cleavage fragment in brains of Machado\u2013Joseph disease patients and transgenic mice is cytotoxic above a critical concentration","volume":"24","author":"Goti","year":"2004","journal-title":"J. Neurosci."},{"key":"2019041604484145800_ref29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado\u2013Joseph disease","volume":"11","author":"Silva-Fernandes","year":"2014","journal-title":"Neurotherapeutics"},{"key":"2019041604484145800_ref30","doi-asserted-by":"crossref","first-page":"E2624","DOI":"10.1073\/pnas.1716071115","article-title":"Karyopherin alpha-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3","volume":"115","author":"Sowa","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019041604484145800_ref31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbr.2004.04.025","article-title":"Characterization of motor skill and instrumental learning time scales in a skilled reaching task in rat","volume":"155","author":"Buitrago","year":"2004","journal-title":"Behav. Brain Res."},{"key":"2019041604484145800_ref32","first-page":"393","volume-title":"Parkinson\u2019s Disease and Movement Disorders","author":"Massaquoi","year":"2002"},{"key":"2019041604484145800_ref33","first-page":"e2609","article-title":"Measuring motor coordination in mice","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"2019041604484145800_ref34","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","article-title":"Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)","volume":"25","author":"Ramsden","year":"2005","journal-title":"J. Neurosci."},{"key":"2019041604484145800_ref35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.870070302","article-title":"Machado\u2013Joseph disease: an autosomal dominant motor system degeneration","volume":"7","author":"Rosenberg","year":"1992","journal-title":"Mov. Disord."},{"key":"2019041604484145800_ref36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0070-2153(06)76003-3","article-title":"Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications","volume":"76","author":"Williams","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"2019041604484145800_ref37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuint.2017.10.013","article-title":"Mass spectrometry analyses of normal and polyglutamine expanded ataxin-3 reveal novel interaction partners involved in mitochondrial function","volume":"112","author":"Kristensen","year":"2018","journal-title":"Neurochem. Int."},{"key":"2019041604484145800_ref38","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019041604484145800_ref39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"2019041604484145800_ref40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"2019041604484145800_ref41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2007.05032.x","article-title":"Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington\u2019s disease","volume":"104","author":"Weiss","year":"2008","journal-title":"J. Neurochem."},{"key":"2019041604484145800_ref42","article-title":"Cerebellar soluble mutant ataxin-3 level decreases during disease progression in spinocerebellar ataxia type 3 mice","volume":"8","author":"Nguyen","year":"2013","journal-title":"PLoS One"},{"key":"2019041604484145800_ref43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins","volume":"56","author":"Ko","year":"2001","journal-title":"Brain Res. Bull."},{"key":"2019041604484145800_ref44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ana.10101","article-title":"Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions","volume":"51","author":"Schmidt","year":"2002","journal-title":"Ann. Neurol."},{"key":"2019041604484145800_ref45","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/ng1105-1155","article-title":"EMPReSS: standardized phenotype screens for functional annotation of the mouse genome","volume":"37","author":"Brown","year":"2005","journal-title":"Nat. Genet."},{"key":"2019041604484145800_ref46","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/bioinformatics\/bti441","article-title":"EMPReSS: European mouse phenotyping resource for standardized screens","volume":"21","author":"Green","year":"2005","journal-title":"Bioinformatics"},{"key":"2019041604484145800_ref47","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/9\/1463\/28378568\/ddy437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T12:35:33Z","timestamp":1720874133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/28\/9\/1463\/5253681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,12,20]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddy437","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5,1]]},"published":{"date-parts":[[2018,12,20]]}}}